Uncategorized

$XPHYF Women in the Psychedelic Field and the Barriers That Held Them Back

Women have contributed greatly to the psychedelics industry, accomplishing incredible research and work in the field, despite being maligned in serious ways for just being involved. Given that International Women’s Month has just ended, the timing seems ideal to shine a spotlight on women pioneers of psychedelics, along with a focus on what exactly held them back.

Women have had to jump through hurdles that did not exist for their male counterparts as well as bypass barriers in various industries and fields, including the field of psychedelic research. Knowledge of history or sometimes just personal experience has shown that the presence of women has been discouraged in education, career options, and other sectors that were dominated by men. While it may not seem like a big deal to some, gender discrimination has hindered a lot of progress from being made.

For instance, when researchers looked into LSD as a possible treatment for alcoholism, gender segregation still barred women from going to pubs, even in the ‘70s, which left men to develop alcoholism treatments. This translated into men also  owning alcoholism LSD-assisted therapy space.

In addition to this, women considering to be in their child-bearing years were excluded and discouraged from taking part in clinical trials, with researchers of the time fearing that their participation would risk the reproductive abilities of their bodies.

The scientists’ reasons obviously hint at the societal misconception that saw women as lesser beings that weren’t smart enough for life sciences. You may have heard the phrase, “a woman’s place is in the kitchen,” which discredits women’s abilities and ties their purpose to the domestic lifestyle, which generally involves producing offspring and cleaning.

Furthermore, many women who persevered and made their mark in research sectors still had to work behind the scenes or co-author their findings with men, sacrificing credit that was deserved and hiding their names in order to enhance the study of psychedelic substances.

With regard to the benefits of psilocybin, it may not be common knowledge that much of what we know about psilocybin mushrooms came Maria Sabina.

In 1955, Maria Sabina shared her knowledge of psilocybin mushrooms with Robert Gordon Wasson and Valentina Wasson. The two researchers presented this research in 1957 through an interview entitled “I Ate the Scared Mushrooms” with Tina’s This Week and a photo essay entitled “Seeking the Magic Mushrooms,” which was published in Life magazine.

Sabina’s revelation brought psilocin and psilocybin into the spotlight, which led Albert Hoffman, who is known as the father of LSD and its discoverer, to focus his attention to psychedelic substances for further research. However, despite the use of a pseudonym to protect Sabina’s identity, she was soon found out; the rest of her story is tragic.

Thanks to the pioneering work done by different people and entities decades ago, many companies such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are advancing psychedelic-medicine formulation programs with an aim of finding remedies to the worsening mental health conditions that seem to be unresponsive to the existing medications.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $XPHYF Women in the Psychedelic Field and the Barriers That Held Them Back

$UEC Announces Impressive PAA-1 Results at Burke Hollow ISR Project

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, today announced its completion of an initial 40 development holes in the first production area (“PAA-1”) of its Burke Hollow ISR Project in South Texas. “We are pleased with the drilling results to date, which continue to improve our understanding of the five Goliad Formation roll fronts or trends within PAA-1,” said Andy Kurrus, VP of Resource Development. “The continuity of the uranium roll fronts, and the exceptional uranium grade intercepts are impressive. The development of Burke Hollow, the only recent uranium discovery in the United States, continues to exhibit the potential to be the largest Goliad Formation deposit ever discovered in the South Texas Uranium Trend. As we plan for additional production areas at Burke Hollow, we have a strong pipeline to our ~19,000 acre property, including defined resources outside of PAA-1 and several exploration targets and anomalous areas that have only been lightly explored.”

To view the full press release, visit https://ibn.fm/QZJHA

About Uranium Energy Corp.

Uranium Energy is a U.S.-based uranium mining and exploration company. As a leading pure-play American uranium company, UEC is advancing the next generation of low-cost and environmentally friendly in-situ recovery (“ISR”) mining uranium projects. In South Texas, the company’s hub-and-spoke operations are anchored by UEC’s fully-licensed Hobson Processing Facility, which is central to its Palangana, Burke Hollow, Goliad and other ISR pipeline projects. In Wyoming, UEC controls the Reno Creek project, which is the largest permitted, pre-construction ISR uranium project in the U.S. Additionally, the company’s diversified holdings provide exposure to a unique portfolio of uranium related assets, including: 1) major equity stake in the only royalty company in the sector, Uranium Royalty Corp; 2) physical uranium warehoused in the U.S.; and 3) a pipeline of resource-stage uranium projects in Arizona, Colorado, New Mexico and Paraguay. In Paraguay, the company owns one of the largest and highest-grade ferro-titanium deposits in the world. The company’s operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at http://ibn.fm/UEC

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $UEC Announces Impressive PAA-1 Results at Burke Hollow ISR Project

$WTER Announces CEFCO Partnership in Continued C-Store Expansion

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, has announced its latest partnership with CEFCO Convenience Stores. According to the update, CEFCO is now selling Alkaline88’s single-serve products in more than 200 high-volume stores across six states. “Adding CEFCO as a customer is a big step in our continued convenience store expansion,” said Ricky Wright, president and CEO of The Alkaline Water Company. “Developing significant partnerships and adding key customers such as CEFCO will allow us to further grow our c-store footprint in addition to expanding distribution of our single-serve products. The continued C-store growth we are seeing is a testament to the strength of our brand and the trust and confidence that our loyal customers have in Alkaline88.”

To view the full press release, visit: https://cnw.fm/B7Wcf

About The Alkaline Water Company Inc.

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products Inc. includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils, and bath salts, along with broad-spectrum hemp, powder packs, oil tinctures, capsules, and gummies. To purchase A88CBD(TM) products online, visit www.A88CBD.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $WTER Announces CEFCO Partnership in Continued C-Store Expansion

$TOBAF Shares Research Study Findings Showing Strong Product Reception

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has announced notable findings from a recent market research study that focused on the TAAT concept, brand image and product-user experience. The two-part market research study was conducted by Toronto-based market research firm Burak Jacobson Partners Inc. among smokers aged 21 years and older living in Ohio, Michigan, Illinois and Pennsylvania. Highlights of the study included more than half of the respondents stated that they definitely would or probably would purchase TAAT products, with more than 28% of those responding definitely would citing the retail price of the product. In addition, the study noted that the ability to purchase TAAT online was a significant factor creating interest in the innovative TAAT tobacco-free and nicotine-free alternative to traditional cigarettes. “Conducting this study among smokers aged 21+ in Ohio and neighboring states after launching the product in Q4 2020 enables us to make near-term business decisions based on a combination of practical and theoretical insights,” said TAAT CEO Setti Coscarella in the press release. “Based on how frequently TAAT is reordered by retailers in Ohio and purchased online by smokers aged 21+ across the country, we know there is continued interest. . . . However, we need far more information than that in order to intelligently plan our efforts to roll TAAT out on a larger scale. In this two-part consumer research study, we learned many things about how TAAT is perceived both as a brand and as a product in concept, in addition to how the user experience of TAAT is regarded among those who sampled it. The responses to this study reinforced our belief that TAAT has several competitive advantages in the USD $814 billion global tobacco industry, including the novel element of being nicotine free and tobacco free, an attractive price point compared to tobacco cigarettes, and the ability to purchase TAAT online. As we expand our market footprint in 2021, we intend to capitalize on these advantages to capture the interest of smokers aged 21+ and further establish TAAT as a better choice and a recognized brand name in the tobacco category.”

To view the full press release, visit https://ibn.fm/fTfvy

About TAAT Lifestyle & Wellness Ltd.

TAAT Lifestyle and Wellness has developed TAAT,  which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $TOBAF Shares Research Study Findings Showing Strong Product Reception

$PBIO Finalizes Plan to Acquire Global Eco-Friendly Agrochemical Supplier

Company Expects Acquisition to be Accretive with Sustained Profitable Revenue Growth,
Leveraging Market-Changing Synergy from PBI’s Ultra Shear Technology Nanoemulsions Platform

SOUTH EASTON, MA / April 14, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, today announced it has finalized terms and executed a new letter of intent to purchase the assets of an internationally-based developer and supplier of organically natural, eco-friendly agrochemicals. This acquisition allows the Company to enter the agrochemical market with sought after alternatives to synthetic pesticides and fertilizers serving the rapidly growing sectors of organic and environmentally sustainable agricultural production worldwide. The parties expect to complete definitive documents and to simultaneously sign and close the transaction within four weeks. Subsequently, the Company expects to initiate a series of announcements regarding the acquired assets, global distributorship arrangements, UST enhancement of key products, purchase order receipts/product shipments, and the expected accretive financial impact of the acquisition.

Global population growth is driving increasing demands on food production. Simultaneously, the world is embracing an awakening to the imperatives of environmental sustainability. While demand is soaring for traditional production-boosting synthetic pesticides and fertilizers, these products are in turn being eclipsed by new generations of eco-friendly agrochemicals. New and old generations of agrochemicals face common challenges in getting oily (hydrophobic) active ingredients to become effectively absorbed and thus “bioavailable” within targeted plant species (whose biochemistry is mostly water-based). PBI’s Ultra Shear Technology™ (“UST™”) nanoemulsification platform, which can make oils effectively soluble in water, is a strategic “change agent” technology platform for this market sector, expected to enable more effective agrochemical dosing while reducing the quantities of expensive active ingredients required. Pesticides, used to control insects that damage crops and severely limit production, are projected to grow in worldwide sales from $84.5 billion in 2019 to $131 billion by 2023. Fertilizers, used to replenish soil with essential nutrients required for better crop growth and production, are expected to achieve global sales of approximately $232 billion by 2025.

Mr. Richard T. Schumacher, President and CEO of PBI, commented: “As previously announced, upon completion, this acquisition of assets will establish PBI with a portfolio of respected brand names in the eco-friendly agrochemicals market, with unique and effective proprietary formulations, advantageous manufacturer relationships, trademarks, intellectual property, registrations and licenses, and access to distributor and end-customer relationships worldwide. We expect these assets to be accretive, driving significant new revenues and profitability by Q4 2021 and substantially in 2022 and beyond.”

Mr. Schumacher continued: “While the acquired assets are expected to be dramatically impactful, we expect that our UST nanoemulsions technology platform will propel a major improvement in the economics and effectiveness of agrochemicals. We are looking forward to the opportunity to leverage the UST technology platform within a diverse line of next-generation, eco-friendly agrochemicals that fall into two of the hottest growth segments in agricultural production worldwide: organic foods and environmental sustainability.”

PBI’s Board Chairman, Mr. Jeffrey N. Peterson expanded on the strategic context of this acquisition: “PBI’s UST platform provides a unique and highly effective route for the creation of nanoemulsions with extremely low and consistent droplet sizes, which offer revolutionary improvements in more effective and economical products with improved sensory profiles, texture, appearance, stability, water solubility, and bioavailability. We expect these products to serve an amazing diversity of large commercial markets, from food and beverages, to cosmetics, nutraceuticals, pharmaceuticals, and now agriculture.”

Mr. Peterson continued: “We have previously announced initial relationships to open up pharmaceutical and hemp-derived product applications, as well as plans to bring PBI into the cosmetics and personal care products markets. This asset acquisition will quickly drive our penetration into the agrochemicals sector; importantly, it also includes products in the commercial, and retail cleaning/disinfection/healthcare arena as well. It is also expected to quickly extend into cosmetics and personal care products. While our overall strategy continues to focus on a licensing and equipment leasing/servicing business model for UST worldwide, this investment into direct participation and potential redefinition of terms of competition within an entire market sector is expected to demonstrate the strategic reach and destiny for our UST platform, which we can extend into many other major market opportunities as well.”

The letter of intent executed between the companies details the milestones that need to be met to complete the transaction, including the completion of all due diligence and acquisition financing.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB:PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Our primary focus is for the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward Looking Statements

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied, or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following website link:

http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter.

CONTACT:
Richard T. Schumacher, President & CEO
(T) 508-230-1828
(F) 508-230-1829

Jeffrey N. Peterson, Chairman
(T) (650) 703-8557

Wednesday, April 14th, 2021 Uncategorized Comments Off on $PBIO Finalizes Plan to Acquire Global Eco-Friendly Agrochemical Supplier

$POAI Study Finds That Sugar Compromises Brain Development in Children

recent study conducted by a faculty member from the University of Georgia, in partnership with a team of researchers from the University of Southern California, has found that the daily consumption of beverages sweetened with sugar during adolescence damages performance on a memory and learning task during adulthood. The group of researchers demonstrated that changes in the bacteria found in the gut could be the key to the memory impairment caused by sugar.

High-sugar diets have also been associated with health effects such as heart disease and obesity as well as impaired memory function.

The research, published in “Translational Psychiatry,” has been released at a time when not much is known about how the excessive consumption of sugar during childhood influences brain development, particularly in a region that’s essential for memory and learning, known as the hippocampus. Given that children are the largest consumers of added sugar, the research couldn’t have come at a better time.

Using a rodent model, the researchers also discovered that when parabacteroides, which are bacteria, were enriched into the guts of animals that had never consumed sugar, similar memory deficits were observed. First author of the study and UGA College of Family and Consumer Sciences assistant professor Emily Noble explained that early-life sugar increased the levels of bacteria, noting that the higher the levels of bacteria were the worse the animals performed on a task. Noble added that they also discovered that the bacteria was enough to damage memory in a way similar to sugar and noted that it also damaged other types of memory functions as well.

A joint publication of the U.S. Departments of Health and Human Services and Agriculture, the Dietary Guidelines for Americans recommends that individuals should limit their intake of added sugars to less than 10% of calories daily.

However, data obtained from the CDC demonstrates that Americans aged between 9 and 18 years of age usually exceed the aforementioned limit, with the majority of the calories coming from beverages that have been sweetened by sugar.

The researchers fed young rats an 11% sugar solution, which is similar to the sugar-sweetened beverages that are commercially available. They then had the rats perform a memory task that was hippocampus dependent, which had been designed to measure episodic contextual memory. The researchers discovered that the rats that ingested sugar in their early life had an impaired ability to remember the context in which they’d seen a familiar object or differentiate whether an object was new to a particular context.

Noble noted that future research was required to better identify different pathways through which gut-brain signaling operates.

One technique that could possibly help researchers better understand how gut-brain signaling occurs, a technique that has been used extensively by Predictive Oncology (NASDAQ: POAI), is data analytics and using artificial intelligence. Predictive Oncology is leveraging this technique to increase the rate at which cancer treatments are personalized.

NOTE TO INVESTORS: The latest news and updates relating to Predictive Oncology (NASDAQ: POAI) are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $POAI Study Finds That Sugar Compromises Brain Development in Children

$PLTXF Launches New Refrigerated and Frozen Product Line

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the addition of perishable, refrigerated and frozen goods to its expanding repertoire of grocery items. According to the update, the company is enhancing product offerings at its one-stop shop for everything plant-based by adding high-quality fresh and frozen products by various brands including Beyond Meat, Impossible Foods, Miyokos, Follow Your Heart, Gardein, Tofurkey and Alpha Foods. The new items are now available to order in the “Frozen” and “Refrigerated” sections of the company’s United States’ e-commerce platform, with the products to be available for shipping to Canadian customers later this year. “Launching the new refrigerated and frozen product line is a natural and thrilling next step for PlantX,” said Julia Frank, PlantX CEO. “By adding such items, we are building on our efforts to create an online presence where customers can access a versatile range of high-quality products that meet their everyday needs.”

To view the full press release, visit https://ibn.fm/T0Wre

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s website at www.Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $PLTXF Launches New Refrigerated and Frozen Product Line

$IDEX Releases 2020 Financial Results, Appoints Chief Revenue Officer to Help Drive Long-Term Growth

  • EV (electric vehicle) revenues amounted to $19.5 million in 2020, growing 600+ percent from $2.7 million in 2019
  • First sales of battery and charging systems also drove revenue in 2020 and are expected to continue growing this year following the acquisition of WAVE
  • New Chief Revenue Officer Kristen Helsel has a proven track record in growing revenues in the automotive and energy management industries and will play an instrumental role in driving the company’s growth, performance and strategy

Ideanomics (NASDAQ: IDEX), a global company focused on enabling the widespread adoption of commercial electric vehicles and associated energy consumption, finished 2020 with significant resources available to drive long-term growth plans and substantially higher EV revenue than in 2019, in spite of the pandemic.

In an earnings release conference call on March 31, the Ideanomics management revealed the full operating results for the year 2020 and provided selected business highlights and updates, including the company’s progress in its Mobility unit activities as a result of its Sales 2 Financing 2 Charging (S2F2C) business model gaining traction in the EV industry (https://ibn.fm/aXDDW).

According to the official financial results, the company’s total revenue for 2020 amounted to $26.8 million, growing sequentially quarter over quarter, demonstrating the growing strength of the Ideanomics model. Gross profit was $2.1 million, which represented a gross margin of 7.7 percent.

Ideanomics is currently generating revenue from its S2F2C business model, which includes three operating features:

  1. Vehicle and Battery Sales – Medici, Treeletrik, Energica, and Solectrac cover the three market segments for the company
  2. Financing, Leasing, and Insurance – Financial services to fleet customers, commission-based delivery, and origination-fee based revenue
  3. Charging and Energy Services – Charging as a service, battery swap programs, and WAVE wireless charging

Most of the total revenue reported for 2020 came from EV operations – more specifically, $19.5 million compared to $2.7 million in 2019, marking an increase of more than 600 percent. In 2020, revenues also included the company’s first sales of battery and charging systems, a major part of the EV ecosystem and Ideanomics’ S2F2C model. Revenues from charging systems are expected to continue growing following the acquisition of inductive charging business WAVE in January 2021, which will be included in the company’s financial results as of the current quarter.

Other key highlights mentioned during the earnings conference call included the acquisition of cash flow positive Timios Holding Corp. under the company’s Capital division in January 2021, investments in leading electric tractor company Solectrac in October 2020 and a purchase agreement with MEG for 2,000 units of D1, a custom electric ride-hailing vehicle, in December 2020.

“We are very pleased with the transformation that took place this past year,” said CEO Alf Poor said. “Despite a year highlighted by COVID-19, we were able to build the groundwork for 2021 and beyond for Ideanomics and we are excited for what the future holds with our recent activity across the EV ecosystem and developments in EV charging infrastructure.”

To further drive its long-term growth, performance and strategy plans and align the activity of its revenue-generating departments, Ideanomics has appointed Kristen Helsel, a proven executive with 20+ years of experience, as Chief Revenue Officer. Throughout her career, Helsel has amassed significant experience growing new business around disruptive technologies by identifying new lucrative deals, while also delivering strong P&L results and combining financial and busines strategies with technical execution for short and long-term gains (https://ibn.fm/lYon2).

Helsel has a proven track record for growing revenues in the automotive and energy management industries and building and leading high-performing sales teams. She has extensive experience in the renewable energy and tech fields, as before joining Ideanomics, she was a partner for DKS Investments, acting as a consultant for organizations in markets such as solar energy and storage, EV charging, robotics, drones, and more. She was also named one of the “Electrifying 100: the 100 Most Influential People” in the EV industry by Automotive News.

Helsel voiced excitement for the new position and her future work to help accelerate the growth of Ideanomics and commercial EV adoption. “I was attracted by the company’s global vision and progress as a leader in the fast-growing commercial EV market, and I am looking forward to leading Ideanomics revenue development as the business continues to scale,” she said.

“We are excited to bring someone on board with experience at the intersection between automotive and energy that is essential to successful EV adoption. Kristen joins Ideanomics at an important time when we are poised for growth in all of our markets,” Poor explained.

The Ideanomics Mobility division is part of a global commercial EV market expected to reach $132.73 billion by 2022, growing at an impressive CAGR of 39.9% from the $34.7 billion value reported in 2018 (https://ibn.fm/icXmZ). Grand View Research projects the global EV charging infrastructure is also expected to grow exponentially, at a rate of 33.4%, to reach $144.97 billion in 2028. The growth of the EV industry is expected to be driven by an increasing interest and support from the public, as more people are looking for a clean alternative to fossil fuel-powered vehicles.

For more information, visit the company’s website at www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $IDEX Releases 2020 Financial Results, Appoints Chief Revenue Officer to Help Drive Long-Term Growth

$UUUU Study Finds That Recycling Battery Minerals Produces Smaller Carbon Footprint

new study conducted by a team of researchers from the Aalto University in Finland has found that the carbon footprint of raw materials acquired through recycling electric vehicle batteries is 38% less than that of virgin raw materials.

In order to reach this conclusion, the researchers used simulation-based life cycle to account for water and energy consumption as well as emissions in smelting, a hydrometallurgical recycling process. Generally, this technique loses various raw materials including lithium while new hydrometallurgical processes work by separating battery metals from waste through dissolution, which allows the minerals to be recovered. However, the process uses up high amounts of chemicals and energy and produces contaminated waste waters.

Despite these faults, the researchers encountered minor overall “side effects” when the battery minerals, in particular aluminum and copper, were recycled, and found that the treatment of mixed waste streams reduced the chemical consumption in leaching. However, they also found a few problem areas.

For instance, in a media statement, lead author of the paper Marja Rinne explained that the researchers noticed that the use of sodium hydroxide as a neutralizing chemical considerably increased the environmental load of their process. The study was published online on “Science Direct.”

Based on their results, Rinne and her colleague researchers suggest using simulation-based life cycle analyses before new techniques are implemented. They note, through their observations, that these evaluations are useful in helping determine how various parameters or choices influence the environmental effects of a process, making them an efficient tool for decision-making that can be used by both policymakers and the industry.

It should be noted that for accurate inventory analysis, process modeling and scenario analysis were carried out.

With the fast adoption of EVs expected to significantly increase the demand for battery metals such as cobalt, nickel and lithium, the researchers also believe that this is the time to develop other methods of recycling. This can be seen in the European Union’s projections, which show that by 2030, the area will be required to host 30 million electric vehicles. This is why the region proposes to recycle 70% of lithium and 95% of copper, nickel and cobalt from electric cars by the end of the decade.

In the brief, study co-author Mari Lundström noted that research on technological innovations and their different effects on the environment go hand in hand, explaining that companies and countries would have to find and use the most ecological and viable recycling processes as the need for recycling will increase significantly in the future.

Sadly, some mining operations contaminate nearby land and water bodies. However, programs such as the one in which Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) could work with the U.S. federal government to remediate mines which were decommissioned during the Cold War, can fix such contamination.

NOTE TO INVESTORS: The latest news and updates relating to Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $UUUU Study Finds That Recycling Battery Minerals Produces Smaller Carbon Footprint

$VVOS Appoints Widely Acclaimed Leader as New Medical Director of Clinical Education

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), today announced the appointment of Mimi Guarneri, MD, FACC as an independent consultant serving in the role of medical director of Clinical Education, effective April 1, 2021. Dr. Guarneri is widely acclaimed as a leading Integrative cardiologist in America and is board-certified in cardiovascular disease, nuclear cardiology and internal and integrative holistic medicine. “We are very excited to welcome Dr. Guarneri to Vivos Therapeutics in this new capacity,” said Kirk Huntsman, Vivos’ chairman and chief executive officer. “As a global medical leader in comprehensive and holistic approaches to cardiovascular disease and sleep disorders, she will be a valuable addition to our growing organization. Her wealth of experience and credibility as an award-winning physician and researcher will help inform other physicians about our breakthrough diagnostic and treatment technologies.”

To view the full press release, visit: https://ibn.fm/JYD5M

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (“OSA”). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have proven effective in over 15,000 patients treated worldwide by more than 1,200 trained dentists. Combining technologies and protocols that alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos System. For more information, visit www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $VVOS Appoints Widely Acclaimed Leader as New Medical Director of Clinical Education

$SBEV Benefits From Strongest U.S. Distilled Spirits Growth Rate in 18 years

April 14, 2021

Splash Beverage Group Inc. (SBEV) Benefits From Strongest U.S. Distilled Spirits Growth Rate in 18 years

  • The North American liquor industry benefitted from a surge in revenue growth in 2020, in spite of widespread restaurant, bar closures
  • U.S. distilled spirits gross revenues rose by 7.7% last year, the biggest percentage increase in 18 years with sales of tequila rising by 17.4% YoY
  • Splash Beverage Group has benefitted from industry’s growth trends, seeing its quarterly sales growth soar nearly 10-fold between Q1-Q42020
  • Splash Beverage has looked to diversify its product portfolio to benefit from ‘off-premise’ sales, including through recent acquisition of ‘Copa Di Vino’

With restaurants and bars shut across much of the United States for the majority of 2020, it would be only natural to assume that the North American liquor industry would have suffered alongside it; a study carried out in 2018 showed that on-premise alcoholic sales in establishments such as bars or restaurants accounted for over a gargantuan $147 billion in sales or 53% of total US alcohol revenues (https://ibn.fm/XpR0i). However, the experience over the past 12 months has been anything but normal. Splash Beverage Group (OTCQB: SBEV), a holding company for a leading portfolio of beverage companies, has been one of the players confounding expectations, having reported cumulative sales of $2.975 million in 2020 – while simultaneously seeing quarterly sales rise nearly tenfold between the first and fourth quarter of the year (https://ibn.fm/Avxhb).

Though impressive, Splash Beverage Group’s strong results may not have come to fruition without the supportive underlying trends witnessed within the U.S. alcoholic beverage industry. The United States Distilled Spirits Council reported that U.S. distilled spirits gross revenues rose by 7.7 percent in 2020, the biggest percentage increase in 18 years and the biggest dollar increase on record (https://ibn.fm/lxJOd). Although restaurant and bar closures contributed to a decline in alcoholic beverage sales during the spring of 2020, monthly consumer spending data showed that a rebound in retail sales combined with a partial recovery in bar and restaurant beverage sales (assisted by several states changing liquor laws to allow them to sell take-away beverages) had driven overall sales higher by the summer (https://ibn.fm/vpTHE).

There was also a notable shift in the type of alcohol being demanding. Whereas the volume of cordials (i.e., liqueurs, amari, etc.) sold declined by 1.8% last year as bars purchased fewer mixers for their cocktails, sales of tequila and mezcal soared, with the alcohol sub-category seeing total sales rise by 17.4% in 2020. Splash Beverage was a particular beneficiary of the trend through increased sales of its SALT Naturally Flavored Tequila brand.

With social distancing regulations still in force across much of the nation, Splash Beverage has sought to increase its emphasis on off-premise channel initiatives as a way to boost revenues for the group. In addition to announcing that its SALT Naturally Flavored tequila had been approved by Walmart in August of last year (https://ibn.fm/SMmkN), Splash Beverage recently completed the acquisition of Copa Di Vino, the nation’s largest ‘wine by the glass’ manufacturer. The company boasts a retail distribution footprint amounting to over 13 thousand outlets across the country (https://ibn.fm/3BKnD).

“Due to the conditions of the current pandemic and social distancing, our primary focus remains on off-premise channel initiatives and we are enjoying growth here,” said Splash Beverage CEO Robert Nistico regarding the company’s recent strategic moves. “We anticipate as bars, restaurants and hotels begin to open, we will experience growth with our relationships in on premise channels.”

For more information, visit the company’s website at www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $SBEV Benefits From Strongest U.S. Distilled Spirits Growth Rate in 18 years

$AMPG Announces Receipt of Developmental Order for Cryogenic Probe Head

AmpliTech Group (NASDAQ: AMPG, AMPGW), a designer, developer, and manufacturer of custom and standard state-of-the-art RF (“RF”) components for commercial, SATCOM, 5G, quantum computing, space, defense and military markets, has received a developmental order for its exclusive cryogenic probe head; the order was received from Amplify My Probe Ltd. The cryogenic device, which uses AmpliTech’s innovative cryogenic low-noise amplifier technology, is designed for use in the study of materials, molecules and drugs for the treatment of diseases. A spin out from the Quantum Spin Dynamics group at the London Centre for Nanotechnology and UCLQAmplify, My Probe commercializes technology to improve the signal-to-noise ratio in EPR experiments. The Amplify My Probe team noted that the device allows the measurements of the electron paramagnetic resonance (“EPR”) experiments to proceed much faster, an estimated 100x speed up of the experiments. The announcement noted that, among possible applications, the device could be used in studies of systems with the potential to design new drugs. The announcement also stated that AmpliTech Group will be the exclusive manufacturer for the cryogenice probe head while Amplify My Probe will be sole global distributor for at least the first 18 months. “We are pleased to work with the Amplify My Probe team to help develop this innovative new product that will advance materials science and medical technology,” said AmpliTech Group CEO Fawad Maqbool in the press release. “AmpliTech Group Inc. is dedicated to be a driving force and leader in amplifier technology for communications and microwave applications that are part of everyday life around us.”

To view the full press release, visit http://ibn.fm/9MCuf

About AmpliTech Group Inc.

AmpliTech Group designs, develops and manufactures custom and standard state-of-the-art RF components for the domestic and international, SATCOM, space, defense and military markets. These designs cover the frequency range from 50 kHz to 40 GHz – eventually, offering designs up to 100 GHz. AmpliTech also provides consulting services to help with any microwave components or systems design problems. The company’s steady growth over the past 13-plus years has come about because it can provide complex, custom solutions for nearly any custom requirements. In addition, AmpliTech Group has the best assemblers, wires, and technicians in the industry and can provide contract assembly of customers’ own designs. For more information about the company, visit www.AmpliTechInc.com.

NOTE TO INVESTORS: The latest news and updates relating to AMPG are available in the company’s newsroom at http://ibn.fm/AMPG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, April 14th, 2021 Uncategorized Comments Off on $AMPG Announces Receipt of Developmental Order for Cryogenic Probe Head

$XPHYF Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

  • Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partner
  • XPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standards
  • The Covid-ID Lab is designed to help beleaguered industries and government regulators quickly screen for the COVID-19 virus at point-of-care sites, and the company expects to begin sales and distribution in April
  • XPhyto has just completed a rebranding effort that includes the launch of a new website
  • The company expects to begin launching other bacteria and virus diagnostic products later this year

With confidence in the world’s mounting recovery from the COVID-19 pandemic growing this year, bioscience industry holding company XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is stepping up its efforts to produce and ultimately commercialize next-generation diagnostic products and new active pharmaceutical ingredients, particularly in regard to the pandemic response.

XPhyto has placed its first order for the company’s Covid-ID Lab product from its exclusive diagnostic development partner, Germany’s 3a-diagnostics GmbH, as announced in a Feb. 24 news release (https://ibn.fm/uBX94). The Covid-ID Lab is a rapid, point-of-care RT-PCR test system for COVID that the company expects to be useful for industry partners and licensees, as well as their respective government regulators, in safeguarding against the spread of the highly infectious and potentially fatal virus.

The first product order from 3a was for 9,600 tests, which are packaged in 200 kits of 48 tests each, according to the company. Delivery is expected this month and XPhyto anticipates they will then undergo evaluation by the company’s partners and the appropriate government agencies for expected commencement of sales in Q2 2021.

“We are pleased to report that all steps towards the launch of Covid-ID Lab remain on track within an ambitious timeline,” XPhyto CEO and Director Hugh Rogers stated in the news release. “Our experienced market launch team is working quickly to bring the product to market, as well as to establish licensing and distribution partnerships. We are confident that Covid-ID Lab, as a 25-minute PCR test with minimal technical and personnel requirements, will be a stand-out product in the COVID-19 test market.”

In March, XPhyto received two critical regulatory approvals in Europe to open the door for sales of its rapid, point-of-care COVID testing solution. On March 10, the company announced approval for commercial production under internationally agreed-on ISO 13485 quality standards (https://ibn.fm/qZCXm). On March 18, the company further announced Covid-ID Lab’s approval for in vitro diagnostic device (CE-IVD) use (https://ibn.fm/PqsZI).

On March 4, XPhyto announced completion of a corporate rebranding initiative that includes the launch of a new website.

“The company is excited to introduce a fresh look at such a pivotal point in our business growth,” Rogers added (https://ibn.fm/A4hzB).

XPhyto is on track to launch sales and distribution in Europe in April, and the company is also in talks with potential distribution and wholesale partners in the Middle East.

XPhyto intends to continue its rapid, point-of-care product development to target other pandemic-potential illnesses, such as H1N1 (swine flu) and H5N1 (avian flu), as well as a variety of other bacterial and viral infectious diseases. New products under an expanding portfolio could be launched before the end of the year.

XPhyto’s research and development operations are located in North America and Europe, but the company’s focus is the European market during these initial stages of product placement.

For more information on XPhyto Therapeutics, visit the company’s newly designed website at www.XPhyto.com.

NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Tuesday, April 13th, 2021 Uncategorized Comments Off on $XPHYF Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

$VTGN Presents Data Regarding Drug Candidate for Replacement of Addictive Benzodiazepines

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, presented data highlighting the proposed mechanism of action (“MOA”) of its Phase 3 investigational drug candidate, PH94B nasal spray, in a poster session at the Anxiety and Depression Association of America’s 2021 Virtual Annual Conference. VTGN’s PH94B spray is designed to provide rapid-onset acute treatment of anxiety without directly activating gamma-amino butyric acid (“GABA-A”) receptors. This approach differentiates PH94B from benzodiazepines such as alprazolam, diazepam and lorazepam, which are direct GABA-A receptor positive modulators. The objective is for PH94B to displace these and other benzodiazepines, which are widely used but addictive, as a viable treatment for social anxiety disorder (“SAD”) and other anxiety disorders and phobias. SAD is the third most common mental health disorder among Americans, and recent studies indicate that an estimated 20 million individuals suffer with the debilitating disorder. “Given the FDA’s recent Drug Safety Communication that outlined and highlighted the safety risks associated with benzodiazepine use, the implications resulting from this study are significant,” said VistaGen chief medical officer Mark Smith, M.D., Ph.D., in the press release. “PH94B may have the potential to displace benzodiazepines altogether and become the safer alternative to help the millions of Americans suffering from anxiety with limited options for safe, effective treatment options. These existing treatments can actually hurt instead of help. We look forward to launching our Phase 3 clinical development program for PH94B next quarter and continuing to push forward in our mission to get it into the hands of those in need as soon as possible.”

To view the full press release, visit http://ibn.fm/guWqd

About VistaGen Therapeutics Inc.

VistaGen is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated potential mechanism of action, has been well tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at http://ibn.fm/VTGN

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Tuesday, April 13th, 2021 Uncategorized Comments Off on $VTGN Presents Data Regarding Drug Candidate for Replacement of Addictive Benzodiazepines

$UEC Focused Strategy Means Price Target Increase, Stronger Position in Growing Sector

  • H.C. Wainwright and Co. increase price target, reiterate buy rating for UEC
  • Key moves by company lead to stronger position
  • UEC investing to build next generation of low-cost and environmentally friendly uranium projects that will be competitive on global basis, says CEO

Recent action taken by Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company that controls one of the country’s largest historical uranium exploration and development databases, has prompted H.C. Wainwright and Co. to increase its price target for the company and reiterate its buy rating (https://ibn.fm/6wWpO). In its updated report, Wainwright specifically cited three main factors for the increase in price: UEC’s decision to obtain financing to support physical uranium purchases, the establishment of a physical uranium inventory initiative and the restart of wellfield development and definition drilling at the company’s Burke Hollow project.

“On March 22, Uranium Energy Corp. (‘UEC’) announced that it had closed an offering for total gross proceeds of $30.5M after issuing 10.0M common shares at a price of $3.05 per share,” the report stated. “These funds are expected to be used for additional uranium purchases, as well as general corporate and working capital requirements. . . . We highlight that UEC’s physical uranium initiative, which we discuss in more detail below, is fully funded with its current cash position, and now includes 1.4M pounds (lbs) of U.S. warehoused uranium.

“While the company remains focused on developing its low-cost, in-situ recovery (‘ISR’) mining capabilities, management has identified a unique opportunity to purchase drummed uranium at spot prices well below global industry mining costs,” the report continues. “As a result, UEC is establishing a physical uranium inventory initiative based on an initial agreement with ConverDyn in Illinois to acquire 0.4Mlbs of U.S. warehoused uranium for a total cost of $10.9M. . . . Management anticipates that this initiative can improve its balance sheet through uranium price appreciation and support future marketing efforts with utilities to accelerate cash flows. Looking ahead, this move should also increase the availability of Texas and Wyoming production capacity for emerging U.S. specific opportunities such as the U.S. Uranium Reserve (‘UR’).”

Finally, the H.S. Wainwright report stated that “on January 26, UEC announced that the company had commenced production area development at its Burke Hollow ISR project in Texas. We note that advancing and expanding resources is a critical step to supporting the company’s plan to participate in supplying the U.S. UR. The UR includes purchases of newly mined domestic uranium over a 10-year period for an aggregate value of $1.5B. Additionally, the FY21 bipartisan omnibus spending bill currently includes $75M for domestically produced uranium. We highlight that the U.S. Department of Energy is currently developing a plan to implement this program, which UEC expects to be a competitive bid process focused on existing fully permitted and low-cost projects.”

As a result of these key factors, H.C. Wainwright and Co. reiterated its buy rating on EUC shares while raising its price target to $5 from $3.60, a move worth noting by one of the country’s oldest and most-trusted financial institutions.

UEC is focused on establishing a stronghold in the growing U.S.-based uranium space. “With $65.8 million in cash and equity holdings, UEC has the balance sheet strength to lead U.S. uranium production higher at the most critical time for the domestic industry since the inception of the civilian nuclear power program began in the 1950s,” said UEC CEO and president Amir Adnani (https://ibn.fm/f3N4T). “As a leading pure-play American uranium company, UEC is investing to build the next generation of low-cost and environmentally friendly uranium projects that will be competitive on a global basis.”

Uranium Energy Corp. is a U.S.-based uranium mining and exploration company that controls one of the country’s largest historical uranium exploration and development databases. Founded in 2003, UEC is headquartered in Corpus Christi, Texas. Properties acquired by the company are primarily located within the United States, including Texas, New Mexico, Colorado, Arizona and Wyoming. In addition, the company is aggressively pursuing other key developmental targets. UEC is poised to be a next-generation uranium producer and is committed to providing low-cost, low-capital fuel for the country’s large electricity-generating nuclear fleet.

For more information, visit the company’s website at www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About MiningNewsWire 

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Tuesday, April 13th, 2021 Uncategorized Comments Off on $UEC Focused Strategy Means Price Target Increase, Stronger Position in Growing Sector

$WTER Texas Legislative Committee Unanimously Approves Medical Cannabis Expansion Bill

Last week, a Texas House committee voted in favor of a bill to expand the state’s medical cannabis program. One of a number of cannabis reform bills discussed by the legislature last week, the legislation was sponsored by House Public Health committee chair Stephanie Klick. The bill is designed to significantly expand Texas’ already-limited medical marijuana Compassionate Use Program (“TCUP”), adding a couple more conditions to the list of diseases that qualify patients for a medical marijuana prescription.

Patients suffering from chronic pain and any type of cancer, as well as veterans with post-traumatic stress disorder, will now be able to take medical marijuana to treat their conditions. Bill HB 1535 will also include debilitating conditions that have been determined by the Department of State Health Services and included on the list of qualifying conditions. On top of that, the legislation will increase the medical marijuana cap for THC (delta-9 tetrahydrocannabinol) from 0.5% to 5%.

Finally, House Bill 1535 would create institutional review boards and authorize those boards to promote studies on medical cannabis and how the state’s medical cannabis program has affected its patients. The 11-0 vote in favor of the legislation came after a landmark committee hearing that included testimonies from physicians, veterans and Texans who were forced to manage or treat their medical conditions with opioids.

Klick, who authored as well as sponsored it, is also responsible for separate legislation that expanded the state’s medical cannabis program to include seizure disorders, multiple sclerosis (“MS”) and terminal cancer in 2019. Klick says the new bill will expand the medical cannabis program again and task Texas Health and Human Services with creating a medical cannabis research program. The legislation has been met with plenty of support from medical cannabis patients, industry stakeholders and drug reform advocates.

According to Texas Original Compassionate Cultivation CEO Morris Denton, the bill is a step in the right direction. However, he concedes that it still isn’t as comprehensive as he would have liked it to be, and his opinion is shared by many. The hope was that the committee would amend the legislation to remove the cap for THC, allow all patients who can benefit from it to use medical cannabis, allow independent laboratories to test marijuana products, and grant physicians and patients in the medical cannabis space legal protections.

Despite this, Texans for Responsible Marijuana Policy isn’t worried. Its representatives as well as Senators will have the chance to make amendments to House Bill 1535 on the floor.

As the debate on the expansion of the medical cannabis bill rages on, there are cannabis products that are legal across the country. To access these products, consumers don’t need a physician’s recommendation. Such products include the CBD-infused tinctures, drinks, powder packs and gummies made by many companies, including The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER).

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Tuesday, April 13th, 2021 Uncategorized Comments Off on $WTER Texas Legislative Committee Unanimously Approves Medical Cannabis Expansion Bill

$TOBAF CEO Scheduled to Present at Global Chinese Financial Forum Virtual Event

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) CEO Settie Coscarella is slated to present at the upcoming Investing in Innovation Global Chinese Financial Forum (“GCFF”). The online event is scheduled for Thursday, April 15; Coscarella’s 20-minute presentation will begin at 1:25 pm EDT and will include an explanation of TAAT’s unique position in the $814 billion global tobacco industry as well as company’s impressive progress since its launch last year. Coscarella will talk about the company’s U.S. product launch in Ohio and online as the company has focused on making the product available to the majority of smokers aged 21 and above in the United States. The GCFF series of events is produced by NAI Interactive Ltd. (“NAI”), a market intelligence and investor relations service provider founded in 1998 with offices in Vancouver and Shanghai; the events are designed to connect North American public companies with Chinese investors. Recent GCFF events include Diversified Investing Strategies, Base Metals & Energy Metals Day, and Precious Metals Day. “Now that we are establishing a presence in our initial market, we have a great story to share with a global audience of investors who may not yet be familiar with TAAT and its unique value proposition for smokers aged 21+,” said TAAT CEO Setti Coscarella in the press release. “The concept of a smokable product with no tobacco or nicotine is very novel, and it has attracted considerable interest from investors in China, whose population of tobacco smokers is approximately eight times the size of Canada’s total population. It has been a pleasure to work with NAI to create a presentation for the GCFF Investing in Innovationevent on Thursday, and I am looking forward to sharing our message with an eager and engaged audience of global investors as we continue to gain momentum with the launch of TAAT in the United States.”

To register for the event, visit https://ibn.fm/E2PC6

To view the full press release, visit https://ibn.fm/4oAnA

About TAATLifestyle & Wellness Ltd.

TAAT Lifestyle and Wellness has developed TAAT,  which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, April 13th, 2021 Uncategorized Comments Off on $TOBAF CEO Scheduled to Present at Global Chinese Financial Forum Virtual Event

$POAI Eyes Expansion of AI-Driven Clinical Models

Predictive Oncology (NASDAQ: POAI) has set sights on other cancers after completing its data generation milestones in a collaborative study with UPMC-Magee Women Hospital. With the comprehensive genomic and transcriptomic sequencing of patient samples now complete, thanks to the study, and patient outcome data having been obtained from UPMC-Magee, “these data will now be used to drive POAI’s AI models of ovarian cancer and their internal ovarian cancer drug re-purposing project.” This is according to an article detailing the matter. “‘The successful generation of high-quality genomic and transcriptomic data from archived materials at Helomics, together with the gathering of historical outcome data from our collaborator UPMC-Magee, demonstrates that we can leverage Helomics’ unique asset and deliver significant value,’ said Predictive Oncology CEO Dr. Carl Schwartz. ‘Furthermore, this project is a template we can use to partner with other health care institutions and expand our AI-driven clinical models to other cancers.’”

To view the full article, visit: https://ibn.fm/fMpmj

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins, including vaccines, antibodies, large and small proteins and protein complexes. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Tuesday, April 13th, 2021 Uncategorized Comments Off on $POAI Eyes Expansion of AI-Driven Clinical Models

$PLTXF Announces Strategic Appointment of the ‘Godfather of Vegan Cuisine’ and Intended Acquisition

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its appointment of Matthew Kenney, a leading plant-based chef, as its new chief culinary officer. Kenney will leverage his business acumen and vision for plant-based cuisine to revolutionize the culinary development at PlantX. His leadership role with PlantX will be facilitated through a new five-year partnership with MK Cuisine Global LLC (“MKC”), Kenney’s plant-based lifestyle brand. In addition, as detailed in the update, the company has entered into a non-binding letter of intent (“LOI”), dated April 12, 2021, pursuant to which PlantX proposes to acquire all of the outstanding limited liability membership interests of MKC’s Plant-Based Deli LLC (“New Deli”). “We are honored and humbled to have the godfather of vegan cuisine lead an important growth segment of PlantX,” said PlantX Founder, Sean Dollinger. “Matthew will provide invaluable wisdom that should give PlantX a competitive edge in the fast-growing plant-based space.” PlantX hosted a press conference at 10:30 a.m. ET today to discuss this collaboration, which is available for viewing at https://ibn.fm/vJJRI.

To view the full press release, visit https://ibn.fm/EJI73

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s website at www.Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, April 13th, 2021 Uncategorized Comments Off on $PLTXF Announces Strategic Appointment of the ‘Godfather of Vegan Cuisine’ and Intended Acquisition

$NETE Highlights of President Biden’s $2 Trillion Infrastructure Plan

Just a few months into his first term, President Joe Biden has unveiled a massive infrastructure plan that would support a mass shift from fossil fuels to clean renewable energy and zero-emission vehicles. The Democrat campaigned on a green-energy platform, pledging to tackle the climate change crisis while simultaneously helping the country’s economy recover from the coronavirus pandemic. Soon after he assumed office, Biden announced a plan to build 500,000 public electric charging stations across the country.

The new infrastructure plan, which was released in late March, outlines his green-energy plan more conclusively. Among other things, the plan would support policies designed to boost electric vehicle (“EV”) adoption, provide funding for half a million public EV charging stations and prepare the electric grid for a mass shift from gas-powered vehicles to EVs. At the moment, EV adoption is held back by a variety of factors, chief among them the high upfront costs drivers have to bear as well as an insufficient and often unreliable network of public charging stations.

According to an official fact sheet released by the White House, Biden’s infrastructure plan sees technology leadership, climate change and more employment opportunities as connected issues that should be addressed together. The plan includes a massive $174 billion investment to boost EV adoption by supporting the retrofitting of factories, reducing reliance on foreign supply chains, boosting the local EV market, and providing job opportunities to develop EV batteries and electric vehicles.

The plan would provide tax incentives and point-of-sale rebates to make zero-emission vehicles more affordable as well as incentive programs and grants to support the development of a network of 500,000 EV chargers by 2030. The Biden administration has already pledged to replace its entire fleet of vehicles with EVs, prioritizing American-made models. The White House has also stated that one of its top priorities is expanding the tax credits EVs are already entitled to.

On top of electrifying the entire federal fleet, Biden’s infrastructure plan would see 50,000 gas-powered transit vehicles replaced with electric models. It would also provide funding for the electrification of 20% of America’s fleet of school buses. Finally, $15 billion has been designated for projects in carbon capture, utility-scale energy storage solutions and rare earth element separations, while $50 billion will be used to fortify the nation’s infrastructure against extreme weather events.

The electric vehicle industry is predictably happy with the infrastructure plan. Fred Krupp, president of the Environmental Defense Fund, notes that zero-emission electric buses and trucks are key to achieving the nation’s climate goals.

The federal infrastructure plan comes at just the time when the EV industry is waiting to see what the planned merger between Mullen Technologies and Net Element (NASDAQ: NETE) has to offer the electric vehicle sector that is evolving rapidly to meet motorists’ needs of today and years to come.

NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Tuesday, April 13th, 2021 Uncategorized Comments Off on $NETE Highlights of President Biden’s $2 Trillion Infrastructure Plan